292 reports of this reaction
1.5% of all LISINOPRIL AND HYDROCHLOROTHIAZIDE reports
#16 most reported adverse reaction
ANGIOEDEMA is the #16 most commonly reported adverse reaction for LISINOPRIL AND HYDROCHLOROTHIAZIDE, manufactured by Almatica Pharma Inc.. There are 292 FDA adverse event reports linking LISINOPRIL AND HYDROCHLOROTHIAZIDE to ANGIOEDEMA. This represents approximately 1.5% of all 19,221 adverse event reports for this drug.
Patients taking LISINOPRIL AND HYDROCHLOROTHIAZIDE who experience angioedema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANGIOEDEMA is a less commonly reported adverse event for LISINOPRIL AND HYDROCHLOROTHIAZIDE, but still significant enough to appear in the safety profile.
In addition to angioedema, the following adverse reactions have been reported for LISINOPRIL AND HYDROCHLOROTHIAZIDE:
The following drugs have also been linked to angioedema in FDA adverse event reports:
ANGIOEDEMA has been reported as an adverse event in 292 FDA reports for LISINOPRIL AND HYDROCHLOROTHIAZIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANGIOEDEMA accounts for approximately 1.5% of all adverse event reports for LISINOPRIL AND HYDROCHLOROTHIAZIDE, making it a notable side effect.
If you experience angioedema while taking LISINOPRIL AND HYDROCHLOROTHIAZIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.